Literature DB >> 35653070

Prevalence and risk factors of barrett's esophagus in lynch syndrome.

Natalie Farha1, Ruishen Lyu2, David Liska3,4, Amit Bhatt5,4, Carole Macaron5,4, Carol A Burke6,7,8.   

Abstract

Lynch syndrome (LS), the most common hereditary cause of colorectal cancer, predisposes to upper gastrointestinal neoplasia. The prevalence of Barrett's esophagus (BE) is elevated in some hereditary gastrointestinal cancer syndromes but has not been systematically evaluated in LS. We assessed the prevalence of BE, BE-related dysplasia, esophageal adenocarcinoma (EAC), and factors associated with BE in LS. Asymptomatic patients with a germline pathogenic variant (PV) in the DNA mismatch repair (MMR) genes undergoing EGD for LS surveillance were identified from a hereditary colorectal cancer registry. We assessed the prevalence of BE and compared demographic, clinical, and endoscopic factors in LS patients with and without BE by logistic regression analysis. 323 patients were included. 21 patients (6.5%) were diagnosed with BE including 38% of females and 33% without gastroesophageal reflux disease (GERD). Dysplasia was diagnosed in two patients (9.5%) and EAC in one (4.8%) patient. Factors associated with BE included male gender (OR 3.00, 1.21-7.46), age at last LS EGD (OR 1.04, 1.01-1.08), presence of hiatal hernia (OR 20.09, 4.57-88.23), hiatal hernia > 3 cm (OR 11.25, 2.41-51.94), and GERD (OR 3.39, 1.32-8.67). No MMR PV was associated with BE. BE was diagnosed in 1 of 15 patients undergoing EGD surveillance for LS and nearly 10% had dysplasia including one EAC. Risk factors associated with BE in LS are similar to those established for BE in the general population. More studies are needed to evaluate if an association between BE and LS exists.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Barrett’s esophagus; Esophageal adenocarcinoma; Lynch Syndrome; MMR

Year:  2022        PMID: 35653070     DOI: 10.1007/s10689-022-00298-w

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  9 in total

1.  Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.

Authors:  Valérie Bonadona; Bernard Bonaïti; Sylviane Olschwang; Sophie Grandjouan; Laetitia Huiart; Michel Longy; Rosine Guimbaud; Bruno Buecher; Yves-Jean Bignon; Olivier Caron; Chrystelle Colas; Catherine Noguès; Sophie Lejeune-Dumoulin; Laurence Olivier-Faivre; Florence Polycarpe-Osaer; Tan Dat Nguyen; Françoise Desseigne; Jean-Christophe Saurin; Pascaline Berthet; Dominique Leroux; Jacqueline Duffour; Sylvie Manouvrier; Thierry Frébourg; Hagay Sobol; Christine Lasset; Catherine Bonaïti-Pellié
Journal:  JAMA       Date:  2011-06-08       Impact factor: 56.272

2.  Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.

Authors:  Sachin Wani; Gary Falk; Matthew Hall; Srinivas Gaddam; Amy Wang; Neil Gupta; Mandeep Singh; Vikas Singh; Keng-Yu Chuang; Vikram Boolchand; Hemanth Gavini; John Kuczynski; Priti Sud; Savio Reddymasu; Ajay Bansal; Amit Rastogi; Sharad C Mathur; Patrick Young; Brooks Cash; David A Lieberman; Richard E Sampliner; Prateek Sharma
Journal:  Clin Gastroenterol Hepatol       Date:  2010-11-27       Impact factor: 11.382

Review 3.  Hiatal hernia and the risk of Barrett's esophagus.

Authors:  Juliana Andrici; Martin Tio; Michael R Cox; Guy D Eslick
Journal:  J Gastroenterol Hepatol       Date:  2013-03       Impact factor: 4.029

Review 4.  Milestones of Lynch syndrome: 1895-2015.

Authors:  Henry T Lynch; Carrie L Snyder; Trudy G Shaw; Christopher D Heinen; Megan P Hitchins
Journal:  Nat Rev Cancer       Date:  2015-02-12       Impact factor: 60.716

5.  Global prevalence of Barrett's oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysis.

Authors:  Leonardo Henry Eusebi; Giovanna Grazia Cirota; Rocco Maurizio Zagari; Alexander Charles Ford
Journal:  Gut       Date:  2020-07-30       Impact factor: 23.059

6.  Barrett's esophagus in the patients with familial adenomatous polyposis.

Authors:  Zoran Gatalica; Mingkui Chen; Carrie Snyder; Sumeet Mittal; Henry T Lynch
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

Review 7.  Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance.

Authors:  Michael B Cook; Aaron P Thrift
Journal:  Gastrointest Endosc Clin N Am       Date:  2020-10-21

8.  Clinically actionable findings on surveillance EGD in asymptomatic patients with Lynch syndrome.

Authors:  Natalie Farha; Jennifer Hrabe; Joseph Sleiman; Jonathan Beard; Ruishen Lyu; Amit Bhatt; James Church; Brandie Heald; David Liska; Gautam Mankaney; Susan Milicia; Michael Silverman; Matthew F Kalady; Carol A Burke
Journal:  Gastrointest Endosc       Date:  2021-07-09       Impact factor: 9.427

9.  Increased prevalence of Barrett's esophagus in patients with MUTYH-associated polyposis (MAP).

Authors:  Ceranza G Daans; Zeinab Ghorbanoghli; Mary E Velthuizen; Hans F A Vasen; George J A Offerhaus; Miangela M Lacle; Peter D Siersema; Margreet G E M Ausems; Jurjen J Boonstra
Journal:  Fam Cancer       Date:  2020-04       Impact factor: 2.375

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.